Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 1,408

Document Document Title
WO/2005/116042A1
The present invention relates to ginsenoside derivatives effective in prevention and treatment of cancer. More specifically, the present invention relates to ginsenoside derivatives with novel structures effective in prevention and treat...  
WO/2005/116049A1
A method for selectively separating desirable steroidal glycosides from undesirable components present in plant material of the Asclepiadaceae family containing the same. The method comprises contacting the plant material or material der...  
WO/2005/095436A1
3-O-β-D-Glucopyranosyl-4-methylerogst-7-en-3-ol or an extract of a liliaceae plant or a fraction thereof containing this compound, which is a composition containing 0.001% by mass or more of the above compound, is used as the active ing...  
WO/2005/084689A1
The invention discloses a Radix astragli extract and production method and use thereof. Such Radix astragli extract mainly comprises astragalus saponin, organic acid and astragalus flavonoid glycoside. Such production method consists of ...  
WO2004024745A3
There is provided a crystalline chemical complex comprising a compound of formula (I) in which the crystal lattice is stabilised by the presence of a guest molecule, characterised in the crystalline complex is of space group P212121 havi...  
WO2004017904A3
The invention features corticosteroids conjugated to either a charged group or a bulky group in a manner that resists in vivo cleavage, the resulting conjugate is a peripherally acting steroid with reduced activity in the central nervous...  
WO/2005/042033A1
The present invention is directed to novel chemical agents for compounds and their use for imaging myocardial perfusion. The invention also is directed to a kit for forming such novel agents. The chemical agents for the present invention...  
WO/2005/040189A1
This invention relates to a group of novel dammarane sapogenin compounds and their use in anti-cancer applications. More particularly, this invention pertains to a novel group of dammarane sapogenin: PPD derivative 1, 2, 3, 4 and PPT der...  
WO2004005313A3
The present invention relates (a) to new compounds represented by Formula I wherein M represents a macrocode subunit (macrolide moiety) derived from macrolide possessing the property of accumulation in inflammatory cells, V represents an...  
WO2004098538A3
The invention describes novel nitrosated and/or nitrosylated compounds of the invention, and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated and/or nitrosylated compound of the inventi...  
WO2004092329A3
The present invention discloses novel saponin derivatives for use with nucleic acids that induce an immune response when administered to animals and humans. The novel saponin derivatives disclosed comprise (a) a saponin aglycone core, wh...  
WO/2005/007172A1
A medical preparation which can maximize the effect of a cholestanol glycoside useful as an antitumor agent. It is a liposome which comprises: a hydrophobic-compound glycoside having an antitumor activity, having GlcNAc-Gal-, GlcNAc-Gal-...  
WO/2004/098538A2
The invention describes novel nitrosated and/or nitrosylated compounds of the invention, and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated and/or nitrosylated compound of the inventi...  
WO/2004/092329A2
The present invention discloses novel saponin derivatives for use with nucleic acids that induce an immune response when administered to animals and humans. The novel saponin derivatives disclosed comprise (a) a saponin aglycone core, wh...  
WO/2004/058796A1
There are provided a promoter containing ginsenoside compound K for the production of hyaluronic acid, and more particularly, a new efficacy of 20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol (compound K), a chief metabolite of ginseng sa...  
WO2003104254A3
The present invention provides novel derivatives comprising compounds in the androstane and androstene series, coupled with ascorbic acid, including salts thereof, and represented by one or more of the general formulae (I), (II), (III): ...  
WO/2004/028475A2
Glycosylceramide analogues are disclosed in which the ceramide moiety and optionally the carbohydrate moiety are modified or replaced. These analogues are useful as immunomodulators, antitumor agents, and as other pharmaceutical agents.  
WO/2004/024745A2
There is provided a crystalline chemical complex comprising a compound of formula (I) in which the crystal lattice is stabilised by the presence of a guest molecule, characterised in the crystalline complex is of space group P212121 havi...  
WO2003043640A3
The present invention relates to a method for the treatment of a patient suffering from major depressive disorder by administering to the patient an effective amount of a glucocorticoid receptor antagonist and to methods for establishing...  
WO/2004/017904A2
The invention features corticosteroids conjugated to either a charged group or a bulky group in a manner that resists in vivo cleavage, the resulting conjugate is a peripherally acting steroid with reduced activity in the central nervous...  
WO/2004/009613A1
There is provided a crystalline chemical complex comprising a compound of formula (I) in which the crystal lattice is stabilised by the presence of a guest molecule, characterised in that the crystalline complex is of space group P212121...  
WO/2004/005313A2
The present invention relates (a) to new compounds represented by Formula I wherein M represents a macrocode subunit (macrolide moiety) derived from macrolide possessing the property of accumulation in inflammatory cells, V represents an...  
WO/2003/104254A2
The present invention provides novel derivatives comprising compounds in the androstane and androstene series, coupled with ascorbic acid, including salts thereof, and represented by one or more of the general formulae (I), (II), (III): ...  
WO/2003/075931A1
A method for the treatment of diabetes mellitus and conditions associated with diabetes mellitus in an animal comprises administering a non-toxic and therapeutically effective amount of one or more of the following compounds: formula (I,...  
WO2003062259A3
A compound of formula (I); wherein R1 represents represents C1-6 alkyl or C1-6 haloalkyl; R2 represents a 4-7 membered non-aromatic ring containing 1-3 heteroatoms selected from O, N and S optionally substituted with one or more methyl o...  
WO/2003/066655A1
According to one aspect of the invention, there is provided a compound of formula (I) in the form of a substantially amorphous solid.  
WO/2003/066026A1
There is provided according to the invention a pharmaceutical formulation comprising an aqueous carrier liquid having dissolved therein: (a) a glucocorticoid of formula (I), wherein R represents ethyl or a 5 membered heterocyclic aromati...  
WO/2003/066032A1
There is provided a pharmaceutical aerosol formulation comprising (i) a compound of formula (I) or a solvate thereof as medicament, (ii) a liquified hydrofluoroalkane (HFA) gas as propellant; and characterised in that the compound of for...  
WO/2003/066036A1
According to one aspect of the invention, there is provided a pharmaceutical formulation for administration by inhalation comprising a compound of formula (I), or a solvate thereof, together with a long−acting β2−adrenoreceptor agon...  
WO/2003/066656A1
There is provided a crystalline complex comprising a compound of formula (I) in which the crystal lattice is stabilised by the presence of a guest molecule, characterised in that the crystalline complex is of space group P212121 having u...  
WO/2003/066024A1
There is provided a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I) or a solvate thereof.  
WO/2003/064445A1
A compound of formula (I): wherein R1 represents C1-6 alkyl or C1-6 haloalkyl; R2 represents a 5 membered heterocyclic aromatic ring containing 1-3 heteroatoms selected from O, N and S optionally substituted with one or more methyl group...  
WO2003035668A3
Novel Anti-inflammatory Androstane DerivativesThere are provided compounds of formula (I) wherein R1 represents O, S or NH;R2 represents -C(=O)-aryl or -C(=O)-heteroaryl;R3 represents hydrogen, methyl (which may be in either the ( or ( c...  
WO/2003/062259A2
A compound of formula (I); wherein R1 represents represents C1-6 alkyl or C1-6 haloalkyl; R2 represents a 4-7 membered non-aromatic ring containing 1-3 heteroatoms selected from O, N and S optionally substituted with one or more methyl o...  
WO2002038166A3
The present invention relates to methods and compositions for the use in treating type 2 diabetes and obesity. More specifically, the invention relates to the methods of screening for the active compound from berries from plants of the P...  
WO/2003/043640A2
The present invention relates to a method for the treatment of a patient suffering from major depressive disorder by administering to the patient an effective amount of a glucocorticoid receptor antagonist and to methods for establishing...  
WO/2003/035668A2
Novel Anti-inflammatory Androstane DerivativesThere are provided compounds of formula (I) wherein R1 represents O, S or NH;R2 represents -C(&equals O)-aryl or -C(&equals O)-heteroaryl;R3 represents hydrogen, methyl (which may be in eithe...  
WO2002079219A3
The present invention is based on the finding that 6-O-acyl-beta-D-glucosyl-beta-sitosterols extracted from fig latex were effective in inhibiting cell proliferation and thus may be used as anti-proliferative agents for the treatment of ...  
WO2002055529A8
A method for recovering soy saponis which comprises extracting a soy isoflavone concentrate derived from soy molasses with a mixture of acetone and water, removing undissolved solids from the extract, cooling the extract such that soy sa...  
WO/2003/022866A1
A cholesterol derivative represented by the following general formula (1), which specifically bonds to ß2−glycoprotein. By using this derivative, ß2−glycoprotein or the like can be highly practically determined. Based on this deter...  
WO2002055529A3
A method for recovering soy saponis which comprises extracting a soy isoflavone concentrate derived from soy molasses with a mixture of acetone and water, removing undissolved solids from the extract, cooling the extract such that soy sa...  
WO/2003/010182A1
This invention relates to a group of novel sapogenins, their use in anti-cancer applications, and to a process for their production. More particularly, this invention pertains to a novel group of dammarane sapogenins, PAM-120, PBM-110 an...  
WO/2002/100879A1
There are provided compounds of formula (I) wherein R¿1? represents C¿1-6? alkyl or C¿1-6? haloalkyl; R¿2? represents a 4-7 membered non-aromatic ring containing 1-3 heteroatoms selected from O, N and S optionally substituted with on...  
WO/2002/094284A1
22,29-epoxy-3,4,6,7,29-pentahydroxy-,(3$g(a),4$g(b),5$g(a),6 $g(a),7$g(b),14$g(b),22S)-stigmastan-15-one is useful for treating dry eye disorders and other disorders requiring the wetting of the eye.  
WO2001042273A9
This invention relates to methods for treating asthma or allergy in a mammal by administering a 3-aminosteroid compound to a mammal in need thereof. The 3-aminosteroid compound being capable of down regulating the IL-9 pathway and allevi...  
WO/2002/079219A2
The present invention is based on the finding that 6-O-acyl-beta-D-glucosyl-beta-sitosterols extracted from fig latex were effective in inhibiting cell proliferation and thus may be used as anti-proliferative agents for the treatment of ...  
WO/2002/072599A1
Efficacious intravenous preparations, skin preparations for external use, mucosal preparations for external use or cosmetics comprising novel ginsenoside derivatives (in particular, dihydroxyginsenoside Rb¿1? or epoxyginsenoside Rb¿1?)...  
WO/2002/069977A1
The invention relates to the use of compounds to treat a number of conditions, such as thrombocytopenia, neutropenia or the delayed effects of radiation therapy. Compounds that can be used in the invention include methyl-2,3,4-trihydroxy...  
WO2001032679A9
A novel glycoside compound for use in treating or preventing cardiovascular disease and it's underlying conditions such as atherosclersis and hypercholeterolemia comprises a carbohydrate moiety and a non-carbohydrate moiety wherein the c...  
WO2002019971A9
The invention relates to 17-Methylene steroids. Method for the production thereof and pharmaceutical compositions containing these compounds. The inventive compounds have an active profile with a hybrid character of such that they act as...  

Matches 151 - 200 out of 1,408